NCT01029535View on ClinicalTrials.gov

Safety and Efficacy of Juvederm® VOLUMA™ for Correction of Mid-face Volume Deficiency

NACompletedINTERVENTIONAL
Enrollment

103

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

April 30, 2011

Study Completion Date

October 31, 2011

Conditions
Mid-face Volume Deficiency
Interventions
DEVICE

Cross-linked hyaluronic acid gel

Cross-linked hyaluronic acid gel (Juvederm® VOLUMA™) up to 4 mLs injected in each side of the face.

Trial Locations (1)

Unknown

Sydney

Sponsors

Lead Sponsor

Allergan
All Listed Sponsors
lead

Allergan

INDUSTRY